Soluble intercellular adhesion molecule 1 and soluble vascular cell adhesion molecule 1 in sudden hearing loss

Otology and Neurotology

Volumn 29, Issue 4, 2008, Pages 470-474

  Quaranta, Nicola ^a,d   Ramunni, Alfonso ^b   Brescia, Paola ^b   D'Elia, Alessandra ^a   Vacca, Angelo ^c   Ria, Roberto ^c  

^a Department of Ophthalmology and Otorhinolaryngology ^*  (Italy)

^b Division of Nephrology   (Brazil)

^c UNIVERSITY OF BARI   (Italy)

^d POLICLINICO   (Italy)

Author keywords

Adhesion molecules; Endothelial dysfunction; SICAM 1; Sudden sensorineural hearing loss; SVCAM 1

Indexed keywords

CHOLESTEROL; FIBRINOGEN; GADOLINIUM; INTERCELLULAR ADHESION MOLECULE 1; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EAR SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEARING LOSS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCEPTION DEAFNESS; PRIORITY JOURNAL; SUDDEN DEAFNESS; VESTIBULOCOCHLEAR NERVE DISEASE; AUDIOMETRY; BLOOD ANALYSIS; GENETICS; HERPES ZOSTER OTICUS; MENIERE DISEASE; METABOLISM; MIDDLE AGED; TINNITUS;

ADOLESCENT; ADULT; AGED; AUDIOMETRY; BLOOD CHEMICAL ANALYSIS; FEMALE; HEARING LOSS, SUDDEN; HERPES ZOSTER OTICUS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MENIERE DISEASE; MIDDLE AGED; TINNITUS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 47249162794     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e318170b650     Document Type: Article

References (27)

1. Byl FM. Sudden hearing loss: eight years experience and suggested prognostic table. Laryngoscope 1984;94:647-71.
2. Slattery WH, Fisher LM, Iqbal Z, Liu N. Oral steroid regimens for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005;132:5-10.
3. Tamhankar M, Solomon D. Acute hearing loss. Curr Treat Options Neurol 2004;6:55-65.
4. Miller J, Dengerink H. Control of inner blood flow. Am J Otolaryngol 1988;9:302-16.
5. Suckfull M. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 2002;360: 1811-7.
6. Mattox D, Simmons F. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463-70.
7. Ciuffetti G, Scardazza A, Srafini G, et al. Whole-blood filterability in sudden deafness. Laryngoscope 1991;101:65-7.
8. Ohinata Y, Makimoto K, Kawakami M, et al. Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol 1994;114:601-7.
9. Suckfull M, Wimmer C, Reichel O, Mees K, Schorn K. Hyperfi-brinogenemia as a risk factor for sudden hearing loss. Otol Neurotol 2002;23:309-11.
10. Rudack C, Langer C, Stoll W, Rust S, Walter M. Vascular risk factors in sudden hearing loss. Thromb Haemost 2006;95: 454-61.
11. Balletshofer B, Stock J, Ritting K, et al. Acute effect of rheopher-esis on peripheral endothelial dysfunction in patients suffering from sudden hearing loss. Ther Apher Dial 2005;9:385-90.
12. Ramunni A, Quaranta N, Saliani MT, et al. Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss? Ther Apher Dial 2006;10:282-6.
13. Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens 2001;14:44S-54S.
14. Shiraishi T, Kubo T, Okomura S, et al. Hearing recovery in sudden deafness patients using a modified defribinogenation therapy. Acta Otolaryngol Suppl 1993;501:46-50.
15. Fettermann BR, Saunders JE, Luxford W. Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 1996;17: 529-36.
16. Koc A, Sanisoglu O. Sudden sensorineural hearing loss: literature survey on recent studies. J Otolaryngol 2003;32:308-13.
17. Ullrich H, Kleinjung T, Steffens T, Jacob P, Schmitz G, Strutz J. Improved treatment of sudden hearing loss by specific fibrinogen aphaeresis. J Clin Apher 2004;19:71-8.
18. Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cyto-kines (AIR Study). Arterioscler Thromb Vasc Biol 2002;22: 1162-7.
19. Libby P. Inflammation in atherosclerosis. Nature 2002;420: 868-74.
20. Ernst E, Resch K. Fibrinogen as a cardiovascular risk factor: a meta-analysis and a review of the literature. Ann Intern Med 1993;118:956-63.
21. Danesh J, Lewington S, Thompson SG, et al. Plasma fibrinogen and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005;294: 1799-1809.
22. Steinberg O. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002;8:1211-7.
23. Gatehouse S, Lowe GD. Whole blood viscosity and red cell filter-ability as factors in sensorineural hearing impairment in the elderly. Acta Otolaryngol Suppl 1990;476:37-43.
24. Browning GG, Gatehouse S, Lowe GD. Blood viscosity as a factor in sensorineural hearing impairment. Lancet 1986;1:121-3.
25. Gatehouse S, Gallacher JE, Lowe GD, et al. Blood viscosity and hearing levels in Caerphilly Collaborative Heart Disease Study. Arch Otolaryngol Head Neck Surg 1989;115:1227-30.
26. Jones NS, Davis A. A retrospective case-controlled study of 1490 consecutive patients presenting to a neuro-otology clinic to examine the relationship between blood lipid levels and sensorineural hearing loss. Clin Otolaryngol 2000;25:511-7.
27. Ramunni A, Ranieri G, Giancipoli G, et al. Is the efficacy of LDL apheresis in ischemic optic neuropathy linked to a reduction in endothelial activation markers? Blood Purif 2006;24:405-12.